Medical Properties Trust (NYSE:MPT) Hits New 12-Month Low – What’s Next?

Posted by Brenda Bartman on Nov 12th, 2026

Medical Properties Trust, Inc. (NYSE:MPT – Get Free Report) hit a new 52-week low during trading on Thursday. The stock traded as low as $1.70 and last traded at $1.71, with a volume of 3,408,668 shares traded. The stock had previously closed at $1.78.

Analysts Set New Price Targets

MPT has been the topic of a number of research reports. Wells Fargo & Company cut their target price on shares of Medical Properties Trust from $5.00 to $3.80 and set an “underweight” rating on the stock in a research note on Tuesday, September 1st. Weiss Ratings upgraded shares of Medical Properties Trust from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday. Royal Bank Of Canada cut Medical Properties Trust from a “sector perform” rating to an “underperform” rating and cut their price objective for the company from $4.50 to $2.00 in a research report on Friday, October 30th. Finally, BNP Paribas Exane downgraded Medical Properties Trust from an “outperform” rating to a “neutral” rating and set a $2.25 target price on the stock. in a report on Tuesday, November 3rd. One equities research analyst has rated the stock with a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Strong Sell” and an average target price of $2.68.

Read Our Latest Stock Analysis on MPT

Medical Properties Trust Trading Down 4.5%

The stock’s fifty day moving average price is $3.07 and its 200 day moving average price is $4.24. The stock has a market cap of $1.00 billion, a P/E ratio of 4.15 and a beta of 1.50. The company has a current ratio of 3.92, a quick ratio of 3.12 and a debt-to-equity ratio of 2.00.

Medical Properties Trust (NYSE:MPT – Get Free Report) last issued its quarterly earnings results on Thursday, October 29th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.02). Medical Properties Trust had a net margin of 24.14% and a return on equity of 5.45%. The business had revenue of $250.14 million for the quarter. Medical Properties Trust’s revenue was up 5.3% compared to the same quarter last year. Equities research analysts expect that Medical Properties Trust, Inc. will post 0.51 earnings per share for the current year.

Hedge Funds Weigh In On Medical Properties Trust

Large investors have recently made changes to their positions in the business. BlackRock Inc. purchased a new stake in shares of Medical Properties Trust in the 2nd quarter worth approximately $347,673,000. State Street Corp raised its stake in Medical Properties Trust by 1.6% during the third quarter. State Street Corp now owns 25,559,914 shares of the company’s stock valued at $90,681,000 after buying an additional 397,627 shares during the last quarter. Allianz Asset Management GmbH purchased a new position in Medical Properties Trust during the second quarter valued at $33,903,000. Advisors Capital Management LLC bought a new stake in Medical Properties Trust in the second quarter worth $30,483,000. Finally, Bank of New York Mellon Corp bought a new stake in Medical Properties Trust in the second quarter worth $28,285,000. 71.79% of the stock is currently owned by hedge funds and other institutional investors.

About Medical Properties Trust

(Get Free Report)

Medical Properties Trust is a real estate investment trust that owns and invests in healthcare facilities, with a primary focus on hospitals. The company leases its properties to healthcare operators and may provide financing related to the acquisition or development of medical facilities. Founded in 2003, Medical Properties Trust has built a portfolio of properties serving acute-care, behavioral health, rehabilitation and other healthcare needs. Its investments have included facilities in the United States and international markets.